Fortress Biotech Inc Pref Series A (FBIOP) stock news · rev $63.3M
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company listed on US.
This FBIOP news page leads with what Fortress Biotech Inc Pref Series A filed — not a scraped headline mill.
No cached 8-K sentence for FBIOP yet. We will not pad this page with generic market recap.
Latest reported FBIOP revenue for 2025-12-31 was $63.3M. Net income was $6.8M. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. FBIOP currently screens at market cap $44.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FBIOP stock page; for the tape open the quote page.
FBIOP stock news FAQ
What are FBIOP's latest revenue and net income?
Latest cached Fortress Biotech Inc Pref Series A (FBIOP) revenue for Dec 31, 2025 was $63.3M. Net income was $6.8M. Statements: https://lician.com/financials/fbiop
How did FBIOP revenue change from the prior cached period?
Cached Fortress Biotech Inc Pref Series A (FBIOP) revenue was up 9.7% from $57.7M (Dec 31, 2024) to $63.3M (Dec 31, 2025). Statements: https://lician.com/financials/fbiop
What is FBIOP's market cap?
Fortress Biotech Inc Pref Series A (FBIOP) market cap is $44.3M on the latest cached fundamentals snapshot.
What kind of company is FBIOP?
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company listed on US.
Where is FBIOP stock news listed?
Cached stock news for Fortress Biotech Inc Pref Series A (FBIOP) is listed at https://lician.com/news/fbiop. Filings: https://lician.com/sec/fbiop
Not investment advice.